M. Tuberculosis H37Rv Infection of Chinese Rhesus Macaques.

Jing Zhang,Yan-Qing Ye,Yong Wang,Ping-Zheng Mo,Qiao-Yang Xian,Yan Rao,Rong Bao,Ming Dai,Jun-Yan Liu,Ming Guo,Xin Wang,Zhi-Xiang Huang,Li-Hua Sun,Zhi-Jiao Tang,Wen-Zhe Ho

DOI: https://doi.org/10.1007/s11481-010-9245-4

2010-01-01

Journal of Neuroimmune Pharmacology

Abstract:Mycobacterium tuberculosis is the most common communicable infectious disease worldwide and the top killer of human immunodeficiency virus (HIV)-infected people. Because of common dual HIV and M. tuberculosis infections, the emergence of multidrug-resistant M. tuberculosis strains, the lack of effective vaccination, the morbidity, and the mortality of M. tuberculosis infection are increasing sharply. Therefore, there is an urgent need for vaccine and drug development against M. tuberculosis infection. These require appropriate animal models that closely resemble human disease. To this end, we infected Chinese rhesus macaques with the M. tuberculosis H37Rv strain. Bronchoscopy was used to inoculate nine monkeys with different doses of M. tuberculosis H37Rv strain. Regardless of the M. tuberculosis dose, all monkeys were infected successfully. This was shown by clinical, laboratory, and histopathology assessments. Among nine infected monkeys, six developed acute rapid progressive tuberculosis and the remaining animals mirrored early-stage chronic disease. These data, taken together, demonstrate that Chinese rhesus macaques are highly susceptible to M. tuberculosis infection and develop similar manifestations of disease that are seen in humans. This model affords new opportunities for studies of M. tuberculosis disease pathology and therapeutics.